Clinicians treating Black SCI patients with ALT concentrations close to the upper limit should carefully consider further evaluation for liver diseases such as cirrhosis and non-alcoholic fatty liver disease [9]. The gene discussed is GPT; the disease is metabolic dysfunction-associated steatotic liver disease.